Pituitary tumors: Cabergoline versus bromocriptine: A meta-analysis?

Mark E. Molitch

doi:10.1038/nrendo.2011.33

Pituitary tumors: Cabergoline versus bromocriptine: A meta-analysis?

Mark E. Molitch

Medicine, Endocrinology Division

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	254-255
Number of pages	2
Journal	Nature Reviews Endocrinology
Volume	7
Issue number	5
DOIs	https://doi.org/10.1038/nrendo.2011.33
State	Published - May 2011

ASJC Scopus subject areas

Endocrinology
Endocrinology, Diabetes and Metabolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/nrendo.2011.33

Cite this

@article{10fdb0b5e8a14279b61611e6b3e067f1,

title = "Pituitary tumors: Cabergoline versus bromocriptine: A meta-analysis?",

author = "Molitch, {Mark E.}",

year = "2011",

month = may,

doi = "10.1038/nrendo.2011.33",

language = "English (US)",

volume = "7",

pages = "254--255",

journal = "Nature Reviews Endocrinology",

issn = "1759-5029",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Pituitary tumors

T2 - Cabergoline versus bromocriptine: A meta-analysis?

AU - Molitch, Mark E.

PY - 2011/5

Y1 - 2011/5

UR - http://www.scopus.com/inward/record.url?scp=79955115435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955115435&partnerID=8YFLogxK

U2 - 10.1038/nrendo.2011.33

DO - 10.1038/nrendo.2011.33

M3 - Article

C2 - 21326279

AN - SCOPUS:79955115435

SN - 1759-5029

VL - 7

SP - 254

EP - 255

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

IS - 5

ER -

Pituitary tumors: Cabergoline versus bromocriptine: A meta-analysis?

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this